281 related articles for article (PubMed ID: 34944056)
21. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
[TBL] [Abstract][Full Text] [Related]
22. The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson's Disease in Zebrafish: The Current Applications and Perspectives.
Abidar S; Hritcu L; Nhiri M
CNS Neurol Disord Drug Targets; 2023; 22(10):1472-1483. PubMed ID: 36306449
[TBL] [Abstract][Full Text] [Related]
23. Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation.
Lai CL; Lu CC; Lin HC; Sung YF; Wu YP; Hong JS; Peng GS
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):420-428. PubMed ID: 30031602
[TBL] [Abstract][Full Text] [Related]
24. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
Mishra A; Singh S; Tiwari V; Bano S; Shukla S
Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson's disease.
Ben Youssef S; Brisson G; Doucet-Beaupré H; Castonguay AM; Gora C; Amri M; Lévesque M
Nutr Neurosci; 2021 Mar; 24(3):197-211. PubMed ID: 31131731
[TBL] [Abstract][Full Text] [Related]
27. Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.
Gonçalves VC; Pinheiro DJLL; de la Rosa T; de Almeida AG; Scorza FA; Scorza CA
Nutrients; 2020 May; 12(6):. PubMed ID: 32466610
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
29. Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson's Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice.
Antunes MS; Cattelan Souza L; Ladd FVL; Ladd AABL; Moreira AL; Bortolotto VC; Silva MRP; Araújo SM; Prigol M; Nogueira CW; Boeira SP
Mol Neurobiol; 2020 Jul; 57(7):3027-3041. PubMed ID: 32458386
[TBL] [Abstract][Full Text] [Related]
30. Ineffectiveness of saxagliptin as a neuroprotective drug in 6-OHDA-lesioned rats.
Turnes JM; Bassani TB; Souza LC; Vital MABF
J Pharm Pharmacol; 2018 Aug; 70(8):1059-1068. PubMed ID: 29766510
[TBL] [Abstract][Full Text] [Related]
31. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.
Yuan WJ; Yasuhara T; Shingo T; Muraoka K; Agari T; Kameda M; Uozumi T; Tajiri N; Morimoto T; Jing M; Baba T; Wang F; Leung H; Matsui T; Miyoshi Y; Date I
BMC Neurosci; 2008 Aug; 9():75. PubMed ID: 18671880
[TBL] [Abstract][Full Text] [Related]
33. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
[TBL] [Abstract][Full Text] [Related]
34. Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease
Zhou H; Shao M; Yang X; Li C; Cui G; Gao C; Di L; Zhong H; Wang Y; Zhang Z; Lee SM
Oxid Med Cell Longev; 2019; 2019():8169125. PubMed ID: 31827703
[TBL] [Abstract][Full Text] [Related]
35. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Sleeman IJ; Boshoff EL; Duty S
Neuropharmacology; 2012 Dec; 63(7):1268-77. PubMed ID: 22971544
[TBL] [Abstract][Full Text] [Related]
37. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
Parra I; Martínez I; Ramírez-García G; Tizabi Y; Mendieta L
Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
[TBL] [Abstract][Full Text] [Related]
38. Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.
Wang Y; Qu L; Wang XL; Gao L; Li ZZ; Gao GD; Yang Q
Mol Neurobiol; 2015 Feb; 51(1):424-36. PubMed ID: 24841382
[TBL] [Abstract][Full Text] [Related]
39. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease.
Mei M; Zhou Y; Liu M; Zhao F; Wang C; Ding J; Lu M; Hu G
Neuropharmacology; 2019 Dec; 160():107758. PubMed ID: 31494143
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]